Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Until today this year the stock’s price performance recorded an increase of 278.12%. However, over the last six months, the performance has been weaker by 227.84%. The price of CAPR decreased -9.85% over the last 30 days. And in the last five days, it has fallen by -1.91%.
Capricor Therapeutics Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $23.40 on 10/15/24, while the lowest price for the same period was registered at $2.80 on 11/21/23.
52-week price history of CAPR Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Capricor Therapeutics Inc’s current trading price is -20.98% away from its 52-week high, while its distance from the 52-week low is 560.33%. The stock’s price range during this period has varied between$2.80 and $23.40. The Capricor Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.86 million for the day, a figure considerably lower than their average daily volume of 3.03 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Capricor Therapeutics Inc (CAPR) has experienced a quarterly rise of 366.92% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 840.61M and boasts a workforce of 102 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.66, with a change in price of +13.85. Similarly, Capricor Therapeutics Inc recorded 2,153,534 in trading volume during the last 100 days, posting a change of +298.49%.
CAPR’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CAPR stands at 0.08. Similarly, the long-term debt-to-equity ratio is also 0.06.
CAPR Stock Stochastic Average
As of today, Capricor Therapeutics Inc’s raw stochastic average for the last 50 days stands at 74.72%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 28.06%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 13.82% and 19.68%, respectively.
